246 related articles for article (PubMed ID: 31907122)
1. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing Breast Ductal Carcinoma In Situ with Microinvasion].
Wu P; Cui L; Guo BH; Wang YC; Cui JS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
[No Abstract] [Full Text] [Related]
2. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
6. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic efficiency of decline rate of signal intensity and apparent diffusion coefficient with different b values for differentiating benign and malignant breast lesions on diffusion-weighted 3.0T magnetic resonance imaging].
Jiang J; Liu W; Ye Y; Wang R; Li F; Peng C
Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(23):1804-7. PubMed ID: 25154847
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
10. [Differential diagnosis for breast ductal carcinoma in situ and plasma cell mastitis by magnetic resonance imaging].
Yang Y; Huang Y; Li P; Hu J; Jiang B; Zhou X; Tan F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1123-1130. PubMed ID: 30523234
[TBL] [Abstract][Full Text] [Related]
11. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
13. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
14. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-tensor imaging as an adjunct to dynamic contrast-enhanced MRI for improved accuracy of differential diagnosis between breast ductal carcinoma in situ and invasive breast carcinoma.
Wang Y; Zhang X; Cao K; Li Y; Li X; Qi L; Tang L; Wang Z; Gao S
Chin J Cancer Res; 2015 Apr; 27(2):209-17. PubMed ID: 25937784
[TBL] [Abstract][Full Text] [Related]
18. Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?
Rahbar H; Parsian S; Lam DL; Dontchos BN; Andeen NK; Rendi MH; Lehman CD; Partridge SC
Clin Imaging; 2016; 40(1):125-9. PubMed ID: 26365872
[TBL] [Abstract][Full Text] [Related]
19. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
20. Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ.
Tao WJ; Zhang HX; Zhang LM; Gao F; Huang W; Liu Y; Zhu Y; Bai GJ
J Appl Clin Med Phys; 2019 Jul; 20(7):142-150. PubMed ID: 31124276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
